<code id='E842408FF6'></code><style id='E842408FF6'></style>
    • <acronym id='E842408FF6'></acronym>
      <center id='E842408FF6'><center id='E842408FF6'><tfoot id='E842408FF6'></tfoot></center><abbr id='E842408FF6'><dir id='E842408FF6'><tfoot id='E842408FF6'></tfoot><noframes id='E842408FF6'>

    • <optgroup id='E842408FF6'><strike id='E842408FF6'><sup id='E842408FF6'></sup></strike><code id='E842408FF6'></code></optgroup>
        1. <b id='E842408FF6'><label id='E842408FF6'><select id='E842408FF6'><dt id='E842408FF6'><span id='E842408FF6'></span></dt></select></label></b><u id='E842408FF6'></u>
          <i id='E842408FF6'><strike id='E842408FF6'><tt id='E842408FF6'><pre id='E842408FF6'></pre></tt></strike></i>

          hotspot

          hotspot

          author:entertainment    Page View:78535
          Cholesterol
          APStock

          Verve Therapeutics said Sunday that the first 10 people to receive a one-time treatment powered by a form of CRISPR called base editing showed reductions in bad cholesterol levels — study results that are preliminary but signal the potential for gene-editing treatments to benefit people with an inherited type of cardiovascular disease.

          Three of the study participants treated with potentially therapeutic doses of the Verve drug, called VERVE-101, showed  reductions in LDL-C levels of 39%, 48%, and 55%, respectively. The latter patient’s decline in so-called “bad” cholesterol was maintained for six months.

          advertisement

          The Verve-101 study results were presented at the American Heart Association conference and are the first data in patients from a therapy that uses base editing to change individual letters of DNA. Verve licensed the base-editing technology from Beam Therapeutics.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Malaria cases in Florida and Texas: Here’s what you need to know
          Malaria cases in Florida and Texas: Here’s what you need to know

          MosquitoscaughtfortestingawaitshipmenttoalabinMcAllen,Texas,inApril2016tobetestedformosquito-bornedi

          read more
          New England Journal of Medicine addresses racist history, slavery
          New England Journal of Medicine addresses racist history, slavery

          AdobeTheNewEnglandJournalofMedicine,theworld’soldestcontinuallypublishedmedicaljournal,publiclyrecko

          read more
          Cancer drug shortages should be causing more outrage
          Cancer drug shortages should be causing more outrage

          DrugshortagesareagrowingproblemintheU.S.,andashortageoflivesavingcancerdrugsinparticularhasreachedcr

          read more

          Insmed lung disease drug hits target in key Phase 3 trial

          AdobeAnexperimentaldrugfromInsmedIncorporatedsuccessfullyreducedlungproblemsamongpatientswithanairwa